Bleeding: Following intravenous high-dose brief-duration Streptokinase therapy in acute myocardial infarction, severe bleeding complications requiring.
Streptokinase (SK) is a thrombolytic medication and enzyme. As a medication it is used to Severe uncontrolled high blood pressure (unresponsive to emergency therapy); For streptokinase, prior treatment within the previous 6 months.
Streptokinase is produced by beta-hemolytic streptococci. of action for anisoylated purified streptokinase activator complex (APSAC) in thrombolytic therapy?.
streptokinase. Streptase. Pharmacologic classification: plasminogen activator. Therapeutic classification: thrombolytic enzyme. Pregnancy risk category C.
J Thromb Thrombolysis. Feb;23(1) Streptokinase--the drug of choice for thrombolytic therapy. Kunamneni A(1), Abdelghani TT, Ellaiah P.
A reappraisal of its therapeutic use in acute myocardial infarction. Streptokinase, the first of the thrombolytic agents to be used in acute myocardial infarction.
methylnortestosterone, The therapeutic efficacy of Streptokinase can be increased when used in combination with methylnortestosterone.
Jul 2, Original Article from The New England Journal of Medicine — Cost Effectiveness of Thrombolytic Therapy with Streptokinase in Elderly Patients.